BMY vs PFE — Performance Comparison
Side-by-side percent change for Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) across every preset interval.
Over the past year, BMY is up 23.34% versus PFE up 12.23% — BMY ahead by 11.10%. Over the past 30 days, BMY is down 2.40% and PFE is down 6.71%. BMY trades at $56.50; PFE at $25.37.
| Ticker | Price | 1D | 3D | 7D | 30D | 90D | YTD | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | $56.50 | -0.48% ★ | +0.09% ★ | +0.61% ★ | -2.40% ★ | -6.98% ★ | +4.75% ★ | +21.11% ★ | +23.34% ★ | -15.70% ★ | -13.69% ★ |
| PFE Pfizer Inc. | $25.37 | -1.50% | -1.95% | -1.23% | -6.71% | -8.03% | +1.87% | +1.22% | +12.23% | -31.46% | -36.76% |
Want to zoom in?
Open the interactive Compare tool to overlay these tickers on a normalized chart, pin any two dates to see the exact return between them, and pick a custom interval.
Open in interactive CompareEach ticker's detail page
BMYBristol-Myers Squibb Company
$56.50-0.48% today
PFEPfizer Inc.
$25.37-1.50% today